
COMED Therapeutics is a biotechnology company developing potentially first-in-class intracellular therapies. Founded in 2019, now headquartered at the Malta Life Sciences Park, COMED is advancing novel technologies that deliver antibodies, proteins, peptides, and RNA directly into cells—unlocking disease targets long considered “undruggable.” Our patented platform enables the delivery of therapeutic molecules into the cellular interior. Combined with our portfolio of patented engineered antibodies, this dual approach creates new opportunities to overcome the limitations of conventional…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.